Proteinase 3/myeloblastin as a growth factor in human kidney cells

Journal of Nephrology

Volumn 16, Issue 6, 2003, Pages 831-840

  Relle, Manfred ^a   Mayet, Werner J ^b   Strand, Dennis ^a   Brenner, Walburgis ^a   Galle, Peter R ^a   Schwarting, Andreas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Nordwest Hospital   (Germany)

Author keywords

Autoimmune disease; Growth factor; Kidney; Morbus Wegener; Myeloblastin; PR3; Proteinase 3; TEC

Indexed keywords

COMPLEMENTARY DNA; GROWTH FACTOR; MYELOBLASTIN; RETROVIRUS VECTOR; TETRAZOLIUM; GREEN FLUORESCENT PROTEIN; GROWTH PROMOTOR; HYBRID PROTEIN; PHOTOPROTEIN; PROTEIN PRECURSOR; SERINE PROTEINASE;

ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA PROBE; DOT HYBRIDIZATION; EPITHELIUM CELL; FETUS; FETUS (ANATOMY); GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; GENETIC VARIABILITY; GROWTH RATE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CELL; KIDNEY TUBULE EPITHELIUM; NORTHERN BLOTTING; PATHOGENESIS; PROTEIN FUNCTION; VIRUS RECOMBINANT; CELL CULTURE; CELL DIVISION; CELL LINE; CONFOCAL MICROSCOPY; CYTOLOGY; ENZYMOLOGY; GENE TRANSFER; GENE VECTOR; IMMUNOBLOTTING; KIDNEY TUBULE; METABOLISM; PHYSIOLOGY; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, NORTHERN; CELL DIVISION; CELL LINE; CELLS, CULTURED; EPITHELIAL CELLS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; GROWTH SUBSTANCES; HUMANS; IMMUNOBLOTTING; KIDNEY TUBULES; LUMINESCENT PROTEINS; MICROSCOPY, CONFOCAL; MYELOBLASTIN; PROTEIN PRECURSORS; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; TRANSDUCTION, GENETIC;

EID: 1642446093     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Braun MG, Csernok E, Gross WL, Muller-Hermelink HK. Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegeners granulomatosis. Immunolocalization in normal and pathologic tissues. Am J Pathol 1991; 139: 831-8.
2. Niles JL, McCluskey RT, Ahmad MF, Arnaout MA. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989; 74: 1888-93.
3. Gullberg U, Bengtsson N, Bulow E, Garwicz D, Lindmark A, Olsson I. Processing and targeting of granule proteins in human neutrophils. J Immunol Methods 1999; 232: 201-10.
4. Adkison AM, Raptis SZ, Kelley DG, Pham CT. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest 2002; 109: 363-71.
5. Salvesen G, Enghild JJ. Zymogen activation specificity and genomic structures of human neutrophil elastase and cathepsin G reveal a new branch of the chymotrypsinogen superfamily of serine proteinases. Biomed Biochim Acta 1991; 50: 665-71.
6. Pham CT, Ley TJ. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci U S A 1999; 96: 8627-32.
7. Zimmer M, Medcalf RL, Fink TM, Mattmann C, Lichter P, Jenne DE. Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc Natl Acad Sci U S A 1992; 89: 8215-9.
8. Rao NV, Rao GV, Marshall BC, Hoidal JR. Biosynthesis and processing of proteinase 3 in U937 cells. Processing pathways are distinct from those of cathepsin G. J Biol Chem 1996; 271: 2972-8.
9. Ludemann J, Utecht B, Gross WL. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990; 171: 357-62.
10. Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH, Hoidal JR. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem 1991; 266: 9540-8.
11. Bories D, Raynal MC, Solomon DH, Darzynkiewicz Z, Cayre YE. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell 1989; 59: 959-68.
12. Gupta SK, Niles JL, McCluskey RT, Arnaout MA. Identity of Wegener's autoantigen (p29) with proteinase 3 and myeloblastin. Blood 1990; 76: 2162.
13. Lutz PG, Moog-Lutz C, Coumau-Gatbois E, Kobari L, Di Gioia Y, Cayre YE. Myeloblastin is a granulocyte colony-stimulating factor-responsive gene conferring factor-independent growth to hematopoietic cells. Proc Natl Acad Sci U S A 2000; 97: 1601-6.
14. Mayet WJ, Csernok E, Szymkowiak C, Gross WL, Meyer zum Buschenfelde KH. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 1993; 82: 1221-9.
15. Sibelius U, Hattar K, Schenkel A, Noll T, Csernok E, Gross WL, Mayet WJ, Piper HM, Seeger W, Grimminger F. Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signalling and leakage response. J Exp Med 1998; 187: 497-503.
16. Pendergraft WF, Alcorta DA, Segelmark M, Yang JJ, Tuttle R, Jennette JC, Falk RJ, Preston GA. ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells. Kidney Int 2000; 57: 1981-90.
17. Taekema-Roelvink ME, Van Kooten C, Heemskerk E, Schroeijers W, Daha MR. Proteinase 3 interacts with a 111-kD membrane molecule of human umbilical vein endothelial cells. J Am Soc Nephrol 2000; 11: 640-8.
18. Schwarting A, Hagen D, Odenthal M, Brockmann H, Dienes HP, Wandel E, Rumpelt HJ, Zum Buschenfelde KH, Galle PR, Mayet W. Proteinase-3 mRNA expressed by glomerular epithelial cells correlates with crescent formation in Wegener's granulomatosis. Kidney Int 2000; 57: 2412-22.
19. Brouwer E, Huitema MG, Mulder AH, Heeringa P, van Goor H, Tervaert JW, Weening JJ, Kallenberg CG. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int 1994; 45: 1120-31.
20. Brockmann H, Schwarting A, Kriegsmann J, Petrow P, Gaumann A, Muller KM, Galle PR, Mayet W. Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis. Arthritis Res 2002; 4: 220-5.
21. Collins SJ, Gallo RC, Gallagher RE. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 1977; 270: 347-9.
22. Gallagher R, Collins S, Trujillo J, McCredie K, Ahearn M, Tsai S, Metzgar R, Aulakh G, Ting R, Ruscetti F, Gallo R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 1979; 54: 713-33.
23. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987; 15: 8125-48.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;.65: 55-63.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
26. Sturrock AB, Franklin KF, Rao G, Marshall BC, Rebentisch MB, Lemons RS, Hoidal JR. Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigen. J Biol Chem 1992; 267: 21193-9.
27. Davies BJ, Pickard BS, Steel M, Morris RG, Lathe R. Serine proteases in rodent hippocampus. J Biol Chem 1998; 273: 23004-11.
28. Kawamoto H, Ohmura K, Katsura Y. Presence of progenitors restricted to T, B, or myeloid lineage, but absence of multipotent stem cells, in the murine fetal thymus. J Immunol 1998; 161: 3799-802.
29. Higashi K, Naito M, Takeya M, Ando M, Araki S, Takahashi K. Ontogenetic development, differentiation, and phenotypic expression of macrophages in fetal rat lungs. J Leukoc Biol 1992; 51: 444-54.
30. Takahashi K, Naito M, Takeya M. Development and heterogeneity of macrophages and their related cells through their differentiation pathways. Pathol Int 1996; 46: 473-85.
31. Garwicz D, Lindmark A, Persson AM, Gullberg U. On the role of the proform-conformation for processing and intracellular sorting of human cathepsin G. Blood 1998; 92: 1415-22.
32. McGuire MJ, Lipsky PE, Thiele DL. Cloning and characterization of the cDNA encoding mouse dipeptidyl peptidase I (cathepsin C). Biochim Biophys Acta 1997; 1351: 267-73.
33. Mantle D. Characterization of dipeptidyl and tripeptidyl aminopeptidases in human kidney soluble fraction. Clin Chim Acta 1991; 196: 135-42.
34. Hammerschmidt R, Kugler P. Peptidases in the kidney of male rats following castration and testosterone substitution. Z Mikrosk Anat Forsch 1984; 98: 137-53.
35. Gullberg U, Lindmark A, Lindgren G, Persson AM, Nilsson E, Olsson I. Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL. J Biol Chem 1995; 270: 12912-8.
36. Witko-Sarsat V, Canteloup S, Durant S, Desdouets C, Chabernaud R, Lemarchand P, Descamps-Latscha B. Cleavage of p21waf1 by proteinase-3, a myeloid-specific serine protease, potentiates cell proliferation. J Biol Chem 2002; 277: 47338-47.
37. Mayet WJ, Hermann E, Csernok E, Knuth A, Poralla T, Gross WL, Meyer zum Buschenfelde KH. A human renal cancer line as a new antigen source for the detection of antibodies to cytoplasmic and nuclear antigens in sera of patients with Wegener's granulomatosis. J Immunol Methods 1991; 143: 57-68.
38. King WJ, Adu D, Daha MR, Brooks CJ, Radford DJ, Pall AA, Savage CO. Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin Exp Immunol 1995; 102: 98-105.
39. Zhou Z, Dionne A, Richard C, Menard HA. On the origin of surface proteinase 3 of nonmyeloid cells: evidence favoring an exogenous source. Clin Immunol 2000; 97: 171-81.
40. Horman S, Fokan D, Galand P. MCF-7 mammary tumour cells express the myeloid cell differentiation controlling factor, serine protease 3/myeloblastin. Cell Prolif 2000; 33: 331-40.
41. Horman S, Del Bino G, Fokan D, Mosselmans R, Galand P. Effect of the serine protease inhibitor N-tosyl-l-phenylalanine-chloromethyl ketone (TPCK) on MCF-7 mammary tumour cells growth and differentiation. Cell Biol Int 2000; 24: 153-61.
42. Hromas R, Orazi A, Neiman RS, Maki R, Van Beveran C, Moore J, Klemsz M. Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU. 1. Blood 1993; 82: 2998-3004.
43. Zhou Z, Richard C, Menard HA. De novo synthesis of proteinase 3 by cytokine primed circulating human polymorphonuclear neutrophils and mononuclear cells. J Rheumatol 2000; 27: 2406-11.
44. Pereira HA. Cationic antimicrobial protein of Mr 37 kDa: a multifunctional inflammatory protein. Chin Med J (Engl) 2001; 114: 9-13.
45. Cunliffe RN, Kamal M, Rose FR, James PD, Mahida YR. Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J Clin Pathol 2002; 55: 298-304.
46. Skold S, Rosberg B, Gullberg U, Olofsson T. A secreted proform of neutrophil proteinase 3 regulates the proliferation of granulopoietic progenitor cells. Blood 1999; 93: 849-56.
47. Zhang M, Zou Z, Maass N, Sager R. Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level. Cancer Res 1995; 55: 2537-41.
48. Zaidi SH, You XM, Ciura S, O'Blenes S, Husain M, Rabinovitch M. Suppressed smooth muscle proliferation and inflammatory cell invasion after arterial injury in elafin-overexpressing mice. J Clin Invest 2000; 105: 1687-95.